Results 141 to 150 of about 2,887,246 (174)

Pipecolic Acid as a Diagnostic Marker of Pyridoxine-Dependent Epilepsy

open access: yesNeuropediatrics, 2005
Pyridoxine-dependent epilepsy, although described some decades ago, may still be an underdiagnosed disorder. We have recently described isolated pipecolic acid elevations in the plasma and/or CSF of three patients with pyridoxine-dependent epilepsy with an intriguing inverse correlation to the oral intake of pyridoxine.
Barbara Plecko, S Stöckler-Ipsiroglu
exaly   +5 more sources

Current Treatment and Management of Pyridoxine-Dependent Epilepsy

open access: yesCurrent Treatment Options in Neurology, 2015
Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder and is considered as a prototypical form of metabolic epilepsy. Characterized by recurrent seizures in the prenatal, neonatal, and/or postnatal periods that are resistant to conventional anti-epileptic drugs, PDE is responsive to pharmacological dosages of pyridoxine. Presently,
Clara D M, van Karnebeek   +1 more
openaire   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Pyridoxine-dependent epilepsy: report on three families with neuropathology

Metabolic Brain Disease, 2016
Pyridoxine-dependent epilepsy (PDE) is a pharmacoresistant epileptogenic encephalopathy controlled by pyridoxine supplementation at pharmacological doses. Despite supplementation, the long-term outcome is often poor possibly because of recurrent seizures and developmental structural brain abnormalities.
Soumeya Bekri   +2 more
exaly   +4 more sources

Gene sleuthing in pyridoxine-dependent epilepsy

Neurology, 2015
Epilepsies caused by inborn errors of metabolism consist of a broad range of diseases, typically with early life onset and often associated with progressive encephalopathy. Early recognition and targeted therapy are key to improved outcomes in several metabolic epilepsies, including those related to the pyridoxal vitamer dependencies.
Weckhuysen, Sarah, Pearl, Phillip L.
openaire   +3 more sources

Timing of therapy and neurodevelopmental outcomes in 18 families with pyridoxine-dependent epilepsy [PDF]

open access: yesMolecular Genetics and Metabolism, 2022
BACKGROUND: Seventy-five percent of patients with pyridoxine-dependent epilepsy due to α-aminoadipic semialdehyde dehydrogenase deficiency (PDE-ALDH7A1) suffer intellectual developmental disability despite pyridoxine treatment.
Sidney M Gospe   +2 more
exaly   +2 more sources

Phenotypic Variability of Pyridoxine-Dependent Epilepsy

open access: yes, 2019
Pyridoxine-dependent epilepsy (PDE) is a rare autosomal recessive disorder characterized by seizures in neonates or infants, which is unresponsive to antiepileptic drugs but controlled by pyridoxine.
ERÇAL, MURAT DERYA   +2 more
openaire   +2 more sources

Congenital cataract in a child with pyridoxine-dependent epilepsy

Journal of American Association for Pediatric Ophthalmology and Strabismus, 2013
Pyridoxine-dependent epilepsy (PDE) is a cause of neonatal epileptic encephalopathy not previously known to cause ophthalmic disease. We describe the novel observation of a 5-year-old girl with pyridoxine-dependent epilepsy and bilateral cataracts. PDE is the result of mutations in the ALDH7A1 gene encoding antiquitin, an enzyme protective against ...
Imran H, Yusuf   +2 more
openaire   +2 more sources

Pyridoxine-dependent epilepsy

2011
This chapter focuses on disorders due to mitochondrial respiratory chain (MRC) dysfunction and use the collective term mitochondrial cytopathy. It discusses two mtDNA disorders, myoclonus epilepsy with ragged red fibers (MERRF) and mitochondrial myopathy encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Epilepsy occurs primarily in the
openaire   +1 more source

Pyridoxine‐dependent epilepsy is more than just epilepsy

Developmental Medicine & Child Neurology, 2019
This commentary is on the original article by Jiao et al. on pages 315–321 of this issue.
openaire   +2 more sources

Pyridoxine-Dependent Epilepsy

2013
A 2-day-old male neonate became increasingly irritable and developed repetitive twitching in the eyelids, face, and limbs around 24 h of life. He was the full-term product of non-consanguineous parents following a normal pregnancy and uneventful spontaneous vaginal delivery. Investigations for infectious etiologies including blood and urine cultures as
openaire   +1 more source

Home - About - Disclaimer - Privacy